Literature DB >> 19061711

Patterns of use and effectiveness of early invasive strategy in non-ST-segment elevation acute coronary syndromes: an assessment by propensity score.

Ignacio Ferreira-González1, Gaietà Permanyer-Miralda, Magda Heras, José Cuñat, Emilia Civeira, Fernando Arós, Juan J Rodríguez, Pedro L Sánchez, Josep R Marsal, Aida Ribera, Jaume Marrugat, Héctor Bueno.   

Abstract

BACKGROUND: The patterns of use and the benefit of an early invasive strategy (EIS) in patients with non-ST-segment elevation acute coronary syndrome in a real-life population are not well established.
METHODS: All consecutive patients hospitalized because of non-ST-segment elevation acute coronary syndrome between November 2004 and June 2005 in 32 randomly selected hospitals were prospectively included. Patients were stratified by their baseline risk profile using the Global Registry of Acute Coronary Events (GRACE) risk score in 2 groups. Inhospital mortality and 1- and 6-month mortality or rehospitalization for acute coronary syndromes were analyzed. To ensure optimal adjustment propensity score, conventional logistic regression and Cox regression were used.
RESULTS: Of 2,856 patients analyzed, 1,616 (56%) had low/intermediate risk (GRACE<or=140) and 1,240 had high risk (GRACE>140). Patients who underwent EIS had lower risk than those who did not (GRACE score 128.2+/-41 vs 138.5+/-43, P<.001). Coronary angiography facility emerged as the strongest predictor of EIS (odds ratio [OR] 13.7 [95% CI 7.1-25]). Patients who underwent EIS had lower rate of the 6-month outcome in both the whole population (9% [95% CI 6.6-11.9] vs 14% [95% CI 12.5-15.6], P=.003) and in high-risk patients (16.5% [95% CI 11-23] vs 23.6% [95% CI 20.8-26.5], P=.04). However, this benefit of EIS was not apparent after statistical adjustment in the whole population (OR 0.8, CI 0.55-1.1, P=.17) or in high-risk patients (OR 0.7, CI 0.46-1.1, P=.16).
CONCLUSIONS: In a real-life population, EIS was mainly performed in patients of low/intermediate risk. An obvious benefit of this strategy could not be found.

Entities:  

Mesh:

Year:  2008        PMID: 19061711     DOI: 10.1016/j.ahj.2008.06.032

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

Review 1.  Non-ST-segment elevation acute coronary syndromes: targeted imaging to refine upstream risk stratification.

Authors:  Henry Chang; James K Min; Sunil V Rao; Manesh R Patel; Orlando P Simonetti; Giuseppe Ambrosio; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2012-07       Impact factor: 7.792

2.  Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome.

Authors:  Subha V Raman; Orlando P Simonetti; Marshall W Winner; Jennifer A Dickerson; Xin He; Ernest L Mazzaferri; Giuseppe Ambrosio
Journal:  J Am Coll Cardiol       Date:  2010-06-01       Impact factor: 24.094

3.  Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and design.

Authors:  Marcus D Flather; Jean Booth; Daphne Babalis; Hector Bueno; Philippe G Steg; Grzegorz Opolski; Filippo Ottani; Jacques Machecourt; Alfredo Bardaji; Mats Bojestig; Anthony R Brady; Bertil Lindahl
Journal:  Trials       Date:  2010-01-14       Impact factor: 2.279

4.  The effect of a regional care model on cardiac catheterization rates in patients with Acute Coronary Syndromes.

Authors:  Helen J Curran; Jaroslav Hubacek; Danielle Southern; Diane Galbraith; Merril L Knudtson; William A Ghali; Michelle M Graham
Journal:  BMC Health Serv Res       Date:  2014-11-08       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.